Bone News and Research

RSS

Endocrine Society announces winners of Early Investigators Awards and FLARE Internship Awards

The Endocrine Society is pleased to announce the recipients of the 2014 Early Investigators Awards and the Future Leaders Advancing Research in Endocrinology Internship Awards.

6 Jun 2014

Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

If you are shot or stabbed in or around Oakland, you are likely to be sent [to Highland Hospital). Oakland has the highest violent crime rate in the nation, so I have indeed seen my fair share of victims over my long career here.

6 Jun 2014

ImStem successfully treats animal model of multiple sclerosis using hESC

ImStem Biotechnology, Inc. (ImStem) announced today it has successfully treated an animal model of multiple sclerosis (MS) using human embryonic stem cells (hESC) derived mesenchymal stem cells (MSCs), called hES-MSCs.

6 Jun 2014

Tolero Pharmaceuticals reports positive interim results from alvocidib Phase 2 trial for AML treatment

Tolero Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company developing treatments for oncology and blood disorders, reported positive interim results from an ongoing, randomized Phase 2 clinical trial of its lead drug candidate, alvocidib, in combination with cytarabine plus mitoxantrone for previously untreated acute myeloid leukemia (AML) patients.

6 Jun 2014

Terminix warns about two serious mosquito-borne diseases in Florida

Terminix, the leading provider of termite and pest control services in the United States, today warned of two serious mosquito-borne diseases which are being reported in Florida. The Florida Department of Health this week issued a report confirming 18 cases of chikungunya virus and 24 cases of dengue fever.

6 Jun 2014

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that Ruben Mesa, MD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 14, 2014 at the 19th Congress of European Hematology Association (EHA) which is being held in Milan, Italy, from June 12-15, 2014.

5 Jun 2014

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Centro Nacional de Investigaciones Oncol-gicas (CNIO) have succeeded in reproducing, in human cells, the chromosomal translocations that cause two types of cancer: acute myeloid leukemia and Ewing's sarcoma.

5 Jun 2014

Scientist unlocks potential of stem cells for repairing neural damage to brain

A QUT scientist is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.

5 Jun 2014

Leukemia researcher wins 2014 Taubman Prize for Excellence in Translational Medical Science

A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014 Taubman Prize for Excellence in Translational Medical Science, awarded by the A. Alfred Taubman Medical Research Institute at the University of Michigan Medical School.

4 Jun 2014

Comparative study shows ultrasonic Bonescalpel makes spine surgery safe, efficient

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced that Dr. Ajay Krishnan of the prestigious Stavya Spine Hospital and Research Center in India concluded after a comparative study in 100 consecutive patients that the BoneScalpel is better than conventional methods in terms of safety and efficacy as it reduces the number of dural tears and neurological deficit, reduces blood loss and shortens operating time.

4 Jun 2014

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation (Nasdaq: INCY) today announced results from the RESPONSE trial, the first pivotal Phase III study evaluating a JAK1/JAK2 inhibitor for the treatment of polycythemia vera (PV).

4 Jun 2014

Parents should take initiative to make sure their hungry teens have healthy fare to eat

Refrigerators and pantries across the country are bracing for the seasonal assault from teenagers who are now done with school and will eat most of their meals at home for the summer months.

4 Jun 2014

Researchers reproduce tumor chromosomal translocations in human cells

Scientists from the Spanish National Cancer Research Centre and the Spanish National Cardiovascular Research Centre have been able to reproduce, for the first time in human cells, chromosomal translocations associated with two types of cancer: acute myeloid leukaemia and Ewing's sarcoma.

4 Jun 2014

ConforMIS announces positive study results of iTotal implant at BASK meeting

ConforMIS, Inc., a medical device company pioneering patient-specific orthopaedic implants, today announced results from several clinical research studies highlighting the benefits of the iTotal® patient-specific total knee replacement.

4 Jun 2014

$Vitamin D with calcium can protect against risk of common bone fractures for seniors$

Vitamin D with calcium can protect against risk of common bone fractures for seniors

For seniors over the age of 65, taking a daily supplement of vitamin D with calcium—but not vitamin D alone—can offer some protection against the risk of common bone fractures, according to an updated review from The Cochrane Library.

4 Jun 2014

Insurer sues Medtronic over bone-growth drug

Humana Inc. alleges the device maker violated federal racketeering statutes by conspiring with prominent physicians to promote unapproved uses of the drug, reports The Wall Street Journal.

3 Jun 2014

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Obese, Caucasian females over age 50 with diabetes and on dialysis because their kidneys have failed are among those at highest risk for the rare and deadly condition calciphylaxis, according to an analysis of the United States Renal Data System.

3 Jun 2014

First Edition: June 3, 2014

Today's headlines include coverage of Medicare data released Monday indicating that 2012 charges for some common inpatient hospital procedures dramatically increased over the previous year.

From Medtronic 3 Jun 2014

Nonadherence triples relapse risk in African American and Asian children in remission from ALL

An estimated 25 percent of children in remission from acute lymphocytic leukemia (ALL) are missing too many doses of an essential maintenance medication that minimizes their risk of relapse, according to a study published online today in Blood, the Journal of the American Society of Hematology.

3 Jun 2014

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

OsteoSymbionics, innovative designer and manufacturer of patient-specific craniofacial implants, is pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance for sterile processing of its signature ClearShield™ cranial implant product, utilizing a novel room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process.

2 Jun 2014

Bone News and Research

Endocrine Society announces winners of Early Investigators Awards and FLARE Internship Awards

Longer looks: When an ER doctor becomes an ER patient; visualizing end-of-life treatments; Google Glass inside operating rooms

ImStem successfully treats animal model of multiple sclerosis using hESC

Tolero Pharmaceuticals reports positive interim results from alvocidib Phase 2 trial for AML treatment

Terminix warns about two serious mosquito-borne diseases in Florida

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Scientist unlocks potential of stem cells for repairing neural damage to brain

Leukemia researcher wins 2014 Taubman Prize for Excellence in Translational Medical Science

Comparative study shows ultrasonic Bonescalpel makes spine surgery safe, efficient

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Parents should take initiative to make sure their hungry teens have healthy fare to eat

Researchers reproduce tumor chromosomal translocations in human cells

ConforMIS announces positive study results of iTotal implant at BASK meeting

Vitamin D with calcium can protect against risk of common bone fractures for seniors

Insurer sues Medtronic over bone-growth drug

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

First Edition: June 3, 2014

Nonadherence triples relapse risk in African American and Asian children in remission from ALL

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News